Abbott Ireland Financing Dac (ABT) 2018-1

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
EUR1,140.0002Sep-20Sr. UnsecuredBaa1BBB-FixedSwapsMS+45 aMS+25-30250.00%-99.72700
EUR1,140.0005Sep-23Sr. UnsecuredBaa1BBB-FixedSwapsMS+75 aMS+55-60500.88%-99.91200
EUR1,140.0008Sep-26Sr. UnsecuredBaa1BBB-FixedSwapsMS+100 aMS+75-80751.50%-99.72300
Tranche Comments
2 yr: Book size: 3100; Registration: Reg S Only; Comments: EUR1.14bn (upsized from EUR1bn) 2yr. Part of 3-trancher. Baa1/BBB. Barc(B&D)/BAML/JPM/MS. IPTs MS+45 area, guidance +25/+30 for 1.14bn size, tbp +25. Books closed 3.1bn+. OBL #171 4/20 +69.5 @100.874, HR 126%. PP: No. XD: No. Tax Call: No; 5 yr: Book size: 3900; Registration: Reg S Only; Comments: EUR1.14bn (upsized from EUR1bn) 5yr. Part of 3-trancher. Baa1/BBB. Barc(B&D)/BAML/JPM/MS. IPTs MS+75 area, guidance +55/+60 for 1.14bn, tbp +50. Books closed 3.9bn+. HR 93% vs DBR 2% Aug 2023+99.8 @110.317. PP: No. XD: No. Tax Call: No; 8 yr: Book size: 5200; Registration: Reg S Only; Comments: EUR1.14bn (upsized from EUR1bn) 8yr. Part of 3-trancher. Baa1/BBB. Barc(B&D)/BAML/JPM/MS. IPTs MS+100 area, guidance +75/+80 for 1.14bn, tbp +75. Books closed 5.2bn+. HR 97% vs DBR 0% Aug 2026+126.4 @97.877. PP: No. XD: No. Tax Call: No;
Guarantor(s)
Abbott Laboratories
Use of Proceeds
Repay notes